Advanced

HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation.

Al-Haidari, Amr LU ; Syk, Ingvar LU and Thorlacius, Henrik LU (2014) In Biochemical and Biophysical Research Communications 446(1). p.68-72
Abstract
Simvastatin is widely used to lower cholesterol levels in patients with cardiovascular diseases, although accumulating evidence suggests that statins, such as simvastatin, also exert numerous anti-tumoral effects.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Biochemical and Biophysical Research Communications
volume
446
issue
1
pages
68 - 72
publisher
Elsevier
external identifiers
  • pmid:24582560
  • wos:000334654900012
  • scopus:84897971002
ISSN
1090-2104
DOI
10.1016/j.bbrc.2014.02.078
language
English
LU publication?
yes
id
94075ff0-4722-41d6-9eef-f08a13f91064 (old id 4384386)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/24582560?dopt=Abstract
date added to LUP
2014-04-01 17:25:26
date last changed
2017-10-01 03:27:05
@article{94075ff0-4722-41d6-9eef-f08a13f91064,
  abstract     = {Simvastatin is widely used to lower cholesterol levels in patients with cardiovascular diseases, although accumulating evidence suggests that statins, such as simvastatin, also exert numerous anti-tumoral effects.},
  author       = {Al-Haidari, Amr and Syk, Ingvar and Thorlacius, Henrik},
  issn         = {1090-2104},
  language     = {eng},
  number       = {1},
  pages        = {68--72},
  publisher    = {Elsevier},
  series       = {Biochemical and Biophysical Research Communications},
  title        = {HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation.},
  url          = {http://dx.doi.org/10.1016/j.bbrc.2014.02.078},
  volume       = {446},
  year         = {2014},
}